Research at NIH is Backed Up Following Shutdown

Share this content:
Research Backlog at NIH Due to Shutdown
Research Backlog at NIH Due to Shutdown

(HealthDay News) -- It will take some time before research programs return to normal at the U.S. National Institutes of Health after the end of the federal government shutdown, officials say.

During the shutdown, 73% of NIH's 18,646 employees were placed on enforced leave, according to Nature, CBS News reported.

About 6,000 researchers in NIH labs who were working on hundreds of experiments suffered a "profound loss of momentum" with their research, the NIH said in a statement to Science magazine. The majority of projects were put on hold and it may take "many months" to restart them.

It will also take time for the office in charge of handing out research grants to return to normal. All October grant applications from researchers have been pushed back to November, and peer review meetings that were planned to take place during the shutdown or this week or next will be rescheduled.

"The shutdown came at one of our busiest periods and it is going to take some time to bring the extramural program back to full strength," Sally Rockey, Ph.D., NIH's Deputy Director for Extramural Research, said in an agency blog, CBS News reported.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs